假体周围关节感染中的多重耐药菌——诊断、预防与治疗
本文综述假体周围关节感染(PJI)中细菌耐药获得机制,并总结PJI诊断、预防和治疗的已有及新兴技术。抗生素联合一期或二期翻修与较高成功率相关,仍是治疗的主要手段。随着抗生素耐药菌检出率升高,需要新型抗生素植入物与伤口护理材料、改进的病原体鉴定方法及明确的病原体特异性治疗算法来优化PJI结局。
要点
- 抗生素联合一期或二期翻修与较高成功率相关,仍是PJI治疗的主要手段。
- PJI诊断与预防的新技术仍在持续探索中。
- 耐药菌检出率升高,需要新型抗生素植入物、伤口护理材料及病原体特异性治疗算法。
核心结论
- 随着抗生素耐药菌检出率升高,需要新型抗生素植入物与伤口护理材料、改进的病原体鉴定方法及明确的病原体特异性治疗算法来优化PJI结局。
研究设计与样本
- 本文为综述,介绍细菌耐药获得机制并总结PJI诊断、预防和治疗的已有及新兴技术。
主要发现
- PJI诊断与预防的新技术仍在持续探索中。
- 抗生素联合一期或二期翻修与较高成功率相关,仍是治疗的主要手段。
临床怎么用
- 抗生素联合一期或二期翻修与较高成功率相关,仍是PJI治疗的主要手段。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periprosthetic joint infection (PJI) is a rare yet challenging problem in total hip and knee arthroplasties. The management of PJI remains difficult primarily due to the evolution of resistance by the infecting organisms. METHODS: This review profiles acquired mechanisms of bacterial resistance and summarizes established and emerging techniques in PJI diagnosis, prevention, and treatment. RESULTS: New techniques in PJI diagnosis and prevention continue to be explored. Antibiotics combined with 1 or 2-stage revision are associated with the higher success rates and remain the mainstay of treatment. CONCLUSION: With higher prevalence of antibiotic-resistant organisms, novel antibiotic implant and wound care materials, improved methods for organism identification, and well-defined organism-specific treatment algorithms are needed to optimize outcomes of PJI.
引用
- Siljander MP, Sobh AH, Baker KC, et al. Multidrug-Resistant Organisms in the Setting of Periprosthetic Joint Infection-Diagnosis, Prevention, and Treatment. J Arthroplasty. 2017. PMID: 28869114. doi:10.1016/j.arth.2017.07.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。